CAF IL-6 expression is upregulated in response to IL-1 secreted by malignant cells, whereas production of TGF-β (by tumor cells) downregulates CAF surface IL-1R, favoring increased matrix secretion by this CAF subtype [80]. Here, IL6 is linked to neoplasm.